Synopsys (SNPS) On Rising Analyst Estimates And Earnings Buzz Looks Undervalued

Fresh analyst reports have pushed Synopsys (SNPS) into focus, with multiple firms lifting earnings estimates and Zacks assigning the stock its top Rank #1 rating ahead of an expected year-over-year earnings and revenue update.

Synopsys has been choppy in the short term, with a 1 day share price gain of 1.81% and a 7 day share price return that declined 5.39%. However, the 90 day share price return of 15.17% points to momentum building off a weaker year to date move, while the 1 year total shareholder return declined 7.33% and the 5 year total shareholder return is up 29.10%.

Scan Synopsys peers with similar earnings sentiment by exploring a curated set of 39 profitable AI stocks that aren't just burning cash that combine AI exposure with positive profit profiles.

So with Synopsys bouncing in the short term but still down for the year, do you lean into today’s price, or wait for a deeper reset as the valuation picture comes into focus next?

Most Popular Narrative: 26% Undervalued

Synopsys last closed at $430.14, while the most followed narrative pegs fair value closer to $584. This indicates a clear gap between price and projected worth, and links that gap to AI led demand and the Ansys acquisition.

The acquisition and integration of Ansys positions Synopsys as the global leader in engineering solutions from silicon to systems. New data showing Q3 FY26 Ansys revenue of about US$711 million and an expected FY26 contribution of about US$2.98 billion supports the view that this expanded portfolio can continue to influence top line growth and operating earnings as cross sell opportunities scale.

See why 168 investors see Synopsys as 26% undervalued.

Result: Fair Value of $583.99 (UNDERVALUED)

Still, the Synopsys story can falter if Ansys integration drags on costs or if ongoing class action and index removal continue to pressure sentiment and liquidity.

Find out about the key risks to this Synopsys narrative.

Another View: Synopsys Through The P/E Lens

There is a clear split. While the narrative points to Synopsys as undervalued, the current P/E of 76.6x is far above the US Software group on 33.7x and above its own fair ratio of 47.4x. That kind of premium can reward patience, or it can magnify disappointment if execution wobbles next.

To pressure test that rich earnings multiple against the underlying numbers, investors can review a fuller valuation breakdown via See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Mixed signals on Synopsys can pull you in both directions, so move quickly, check the underlying data, and weigh the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Synopsys?

Do not stop at Synopsys. Use fresh data, widen your watchlist, and give yourself more options before your next move in the market.

• Target potential mispricing by reviewing a focused set of 27 high quality undervalued stocks that combine quality fundamentals with compressed valuations.
• Strengthen portfolio resilience by scanning a 30 resilient stocks with low risk scores that screens for businesses with more stable risk profiles.
• Get ahead of the crowd by checking a 21 high quality undiscovered gems before they become widely followed.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com